In his session as IAS 2019, Myron Cohen, MD, discussed new long-acting injectables for HIV prevention and the ongoing trials that will determine the efficacy of each.
The impact of tenofovir-containing pre-exposure prophylaxis on bone mineral density may vary depending on an individual’s adherence. Authors of a new study assessed the effect of the only FDA-approved PrEP...
Tuberculosis is common among patients with HIV. Therefore, the authors of a new study set out to find a point-of-care test that can screen for TB quickly and accurately.
To better understand immune reconstitution in children with HIV taking antiretroviral therapy, researchers compared immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in...
Researchers from Australia investigated the incidence of and behavioral risk factors associated with STIs, as well as the changes in STI incidence after preexposure prophylaxis initiation.
As effective HIV interventions have been identified, the design and interpretation of HIV prevention trials has evolved. David Dunn, from University College London, explained these changes during CROI...
For the first time, the US Preventive Services Task Force has made recommendations for all at-risk populations of HIV infection to receive PrEP therapy. To see which populations are included in this...
Researchers designed a survey to determine whether pregnant women with HIV knew their partner’s HIV status, their prevention or treatment plan, and if they had health insurance.
